132 related articles for article (PubMed ID: 7769237)
21. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
22. Development of a simple radioimmunoassay for human C3a.
Lamche HR; Paul E; Schlag G; Redl H; Hammerschmidt DE
Inflammation; 1988 Jun; 12(3):265-76. PubMed ID: 3262087
[TBL] [Abstract][Full Text] [Related]
23. Complement activation in neonatal disease.
Zilow EP
Eur J Pediatr; 1993 May; 152(5):459-60. PubMed ID: 8319722
[No Abstract] [Full Text] [Related]
24. Complement anaphylatoxin C3a as a novel independent prognostic marker in heart failure.
Gombos T; Förhécz Z; Pozsonyi Z; Széplaki G; Kunde J; Füst G; Jánoskuti L; Karádi I; Prohászka Z
Clin Res Cardiol; 2012 Aug; 101(8):607-15. PubMed ID: 22373875
[TBL] [Abstract][Full Text] [Related]
25. Thrombolytic treatment and complement activation.
Agostoni A; Gardinali M; Frangi D; Cugno M; Cafaro C; Conciato L; Sponzilli C; Salmoirago E
Ann Ital Med Int; 1994; 9(3):178-9. PubMed ID: 7946896
[TBL] [Abstract][Full Text] [Related]
26. Increased anaphylatoxins (C3a and C4a) in psoriatic sera.
Ohkohchi K; Takematsu H; Tagami H
Br J Dermatol; 1985 Aug; 113(2):189-96. PubMed ID: 3875363
[TBL] [Abstract][Full Text] [Related]
27. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis.
Himmelfarb J; McMonagle E; Holbrook D; Toth C
J Lab Clin Med; 1995 Oct; 126(4):392-400. PubMed ID: 7561449
[TBL] [Abstract][Full Text] [Related]
28. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
Närkiö-Mäkelä M; Teppo AM; Meri S
Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
[TBL] [Abstract][Full Text] [Related]
29. Quantitation of the anaphylatoxin C3a in the presence of C3 by a novel sandwich ELISA using monoclonal antibody to a C3a neoepitope.
Zilow G; Naser W; Rutz R; Burger R
J Immunol Methods; 1989 Jul; 121(2):261-8. PubMed ID: 2503562
[TBL] [Abstract][Full Text] [Related]
30. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
Burger R; Zilow G; Bader A; Friedlein A; Naser W
J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
[TBL] [Abstract][Full Text] [Related]
31. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
[TBL] [Abstract][Full Text] [Related]
32. Assessment of complement activation during membrane-based plasmapheresis procedures.
Burnouf T; Eber M; Kientz D; Cazenave JP; Burkhardt T
J Clin Apher; 2004; 19(3):142-7. PubMed ID: 15493055
[TBL] [Abstract][Full Text] [Related]
33. Determination of anaphylatoxin concentrations in suction blisters in patients with psoriasis.
Ohkohchi K; Takematsu H; Tagami H
J Invest Dermatol; 1986 Jul; 87(1):65-7. PubMed ID: 3487596
[TBL] [Abstract][Full Text] [Related]
34. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
[TBL] [Abstract][Full Text] [Related]
35. Complement and anaphylatoxin responses to cross-clamping of the aorta. Studies during general anaesthesia with or without extradural blockade.
Bengtson A; Lannsjö W; Heideman M
Br J Anaesth; 1987 Sep; 59(9):1093-7. PubMed ID: 3499158
[TBL] [Abstract][Full Text] [Related]
36. Complement activation from protamine sulfate administration after coronary angiography.
Click RL; Homburger HA; Bove AA
Cathet Cardiovasc Diagn; 1989 Apr; 16(4):221-5. PubMed ID: 2785004
[TBL] [Abstract][Full Text] [Related]
37. Decreased formation of the complement component C4A in leukocyte-depleted stored whole blood.
Schleuning M; Utz H; Heim M; Mempel W
Beitr Infusionsther; 1992; 30():182-5. PubMed ID: 1284702
[TBL] [Abstract][Full Text] [Related]
38. Anaphylatoxin and terminal complement complexes in red cell salvage.
Bengtsson A; Lisander B
Acta Anaesthesiol Scand; 1990 Jul; 34(5):339-41. PubMed ID: 2389647
[TBL] [Abstract][Full Text] [Related]
39. Plasmin activity and complement activation during storage of citrated platelet concentrates.
Bode AP; Miller DT; Newman SL; Castellani WJ; Norris HT
J Lab Clin Med; 1989 Jan; 113(1):94-102. PubMed ID: 2521240
[TBL] [Abstract][Full Text] [Related]
40. Complement gene expression is regulated by pro-inflammatory cytokines and the anaphylatoxin C3a in human tenocytes.
Busch C; Girke G; Kohl B; Stoll C; Lemke M; Krasnici S; Ertel W; Silawal S; John T; Schulze-Tanzil G
Mol Immunol; 2013 Apr; 53(4):363-73. PubMed ID: 23070120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
